Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. uri icon

authors

  • Hagström, Emil
  • Jukema, J Wouter
  • Liberopoulos, Evangelos
  • Marx, Nikolaus
  • McGinniss, Jennifer
  • Manvelian, Garen
  • Pordy, Robert
  • Scemama, Michel
  • White, Harvey D
  • Zeiher, Andreas M
  • Schwartz, Gregory G
  • Steg, P Gabriel
  • Szarek, Michael
  • Bhatt, Deepak L
  • Bittner, Vera A
  • Danchin, Nicolas
  • Diaz, Rafael
  • Goodman, Shaun G
  • Harrington, Robert A

publication date

  • January 1, 2022